Moonrise Medical

Moonrise Medical

AI-enabled ultrasound technology for peripheral vascular disease.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
*

$500k

Grant
Total Funding000k
Notes (0)
More about Moonrise Medical
Made with AI
Edit

Moonrise Medical is a Canadian medical device startup founded in 2021 that is developing an AI-enabled, ultrasound-based technology to improve the diagnosis and treatment of peripheral vascular disease. The company is headquartered in Hamilton, Ontario. The founders include CEO Adam Gold, who has over 20 years of experience in medtech product development, COO Dr. Abubaker Khalifa, an experienced clinician, and CSO Jill Sommerset, who has over 25 years of vascular ultrasound research experience. All three are alumni of the Stanford Biodesign program.

The company's core product is an automated, high-performance ultrasound system designed to evaluate blood flow hemodynamics in the peripheral vascular system. This technology specifically targets the diagnosis and management of conditions like Peripheral Artery Disease (PAD) and Diabetic Foot Ulcers (DFU), with the goal of preventing amputations. The system uses a specialized measurement technique called pedal acceleration time to assess blood flow, allowing non-specialist healthcare workers like nurses and technologists to perform rapid and accurate vascular assessments. This aims to solve the problem of delayed or inaccurate diagnoses that can lead to preventable limb loss, particularly in marginalized communities.

Moonrise Medical's device provides real-time objective metrics to guide interventions and surgeries, helping clinicians decide which and how many blocked vessels to treat. The business model appears to be focused on selling this diagnostic device to clinics, hospitals, and operating suites to enable early, accurate diagnosis and personalized treatment. The company has received investment from Providence Health Care Ventures, Creative Destruction Lab, INOVAIT, and a $500,000 investment from the Ontario Centre of Innovation (OCI) to accelerate development, clinical validation, and regulatory submission processes, including seeking FDA approval.

Keywords: AI-enabled ultrasound, peripheral vascular disease, peripheral artery disease, diabetic foot ulcers, medical device, vascular diagnostics, limb salvage, ultrasound technology, flow hemodynamics, medical imaging, medtech, Adam Gold, Abubaker Khalifa, Jill Sommerset, pedal acceleration time, non-invasive diagnostics, wound care, amputation prevention, diagnostic equipment, healthcare technology

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads